DPP4 inhibitors reduce the degradation of incretins, as a result rising glucose-dependent insulin release. In patients with type 2 diabetic issues, they are considered weight neutral. New data suggest that in obese women with PCOS, DPP4 inhibitors have beneficial effects on weight loss and lessen blood glucose degrees.Acne. Male hormones could make… Read More